Astragaloside IV-induced BMSC exosomes promote neovascularization and protect cardiac function in myocardial infarction mice via the miR-411/HIF-1α axis

References

• Chen B, Luo L, Wei X, et al. M1 bone marrow-derived macrophage-derived extracellular vesicles inhibit angiogenesis and myocardial regeneration following myocardial infarction via the MALAT1/MicroRNA-25-3p/CDC42 axis. Oxid Med Cell Longev. 2021;2021:9959746. doi: 10.1155/2021/9959746.
   PubMedGoogle Scholar
• Sun J, Shen H, Shao L, et al. HIF-1alpha overexpression in mesenchymal stem cell-derived exosomes mediates cardioprotection in myocardial infarction by enhanced angiogenesis. Stem Cell Res Ther. 2020;11(1):373. doi: 10.1186/s13287-020-01881-7.
   PubMed Web of Science ®Google Scholar
• Fu WB, Wang WE, Zeng CY. Wnt signaling pathways in myocardial infarction and the therapeutic effects of wnt pathway inhibitors. Acta Pharmacol Sin. 2019;40(1):9–12. doi: 10.1038/s41401-018-0060-4.
   PubMed Web of Science ®Google Scholar
• Mao Q, Liang XL, Zhang CL, et al. LncRNA KLF3-AS1 in human mesenchymal stem cell-derived exosomes ameliorates pyroptosis of cardiomyocytes and myocardial infarction through miR-138-5p/Sirt1 axis. Stem Cell Res Ther. 2019;10(1):393. doi: 10.1186/s13287-019-1522-4.
   PubMed Web of Science ®Google Scholar
• Doenst T, Haverich A, Serruys P, et al. PCI and CABG for treating stable coronary artery disease: JACC review topic of the week. J Am Coll Cardiol. 2019;73(8):964–976. doi: 10.1016/j.jacc.2018.11.053.
   PubMed Web of Science ®Google Scholar
• Mackman N, Bergmeier W, Stouffer GA, et al. Therapeutic strategies for thrombosis: new targets and approaches. Nat Rev Drug Discov. 2020;19(5):333–352. doi: 10.1038/s41573-020-0061-0.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Wang L, Wang S, et al. Signaling pathways and targeted therapy for myocardial infarction. Signal Transduct Target Ther. 2022;7:78.
   PubMed Web of Science ®Google Scholar
• Zheng H, Liang X, Han Q, et al. Hemin enhances the cardioprotective effects of mesenchymal stem cell-derived exosomes against infarction via amelioration of cardiomyocyte senescence. J Nanobiotechnol. 2021;19(1):332. doi: 10.1186/s12951-021-01077-y.
   PubMed Web of Science ®Google Scholar
• Xu R, Zhang F, Chai R, et al. Exosomes derived from pro-inflammatory bone marrow-derived mesenchymal stem cells reduce inflammation and myocardial injury via mediating macrophage polarization. J Cell Mol Med. 2019;23(11):7617–7631. doi: 10.1111/jcmm.14635.
   PubMed Web of Science ®Google Scholar
• Chen G, Wang M, Ruan Z, et al. Mesenchymal stem cell-derived exosomal miR-143-3p suppresses myocardial ischemia-reperfusion injury by regulating autophagy. Life Sci. 2021;280:119742. doi: 10.1016/j.lfs.2021.119742.
   PubMed Web of Science ®Google Scholar
• Zhang X, Qu H, Yang T, et al. Astragaloside IV attenuate MI-induced myocardial fibrosis and cardiac remodeling by inhibiting ROS/caspase-1/GSDMD signaling pathway. Cell Cycle. 2022;21(21):2309–2322. doi: 10.1080/15384101.2022.2093598.
   PubMed Web of Science ®Google Scholar
• Zheng Q, Zhu JZ, Bao XY, et al. A preclinical systematic review and meta-analysis of astragaloside IV for myocardial ischemia/reperfusion injury. Front Physiol. 2018;9:795. doi: 10.3389/fphys.2018.00795.
   PubMed Web of Science ®Google Scholar
• Shi H, Zhou P, Gao G, et al. Astragaloside IV prevents acute myocardial infarction by inhibiting the TLR4/MyD88/NF-kappaB signaling pathway. J Food Biochem. 2021;45(7):e13757. doi: 10.1111/jfbc.13757.
   PubMed Web of Science ®Google Scholar
• Cheng S, Zhang X, Feng Q, et al. Astragaloside IV exerts angiogenesis and cardioprotection after myocardial infarction via regulating PTEN/PI3K/akt signaling pathway. Life Sci. 2019;227:82–93. doi: 10.1016/j.lfs.2019.04.040.
   PubMed Web of Science ®Google Scholar
• Sha Z, Liu W, Jiang T, et al. Astragaloside IV induces the protective effect of bone marrow mesenchymal stem cells derived exosomes in acute myocardial infarction by inducing angiogenesis and inhibiting apoptosis. Biotechnol Genet Eng Rev. 2023:1–18. doi: 10.1080/02648725.2023.2194087.
   PubMed Web of Science ®Google Scholar
• Shariati A, Nemati R, Sadeghipour Y, et al. Mesenchymal stromal cells (MSCs) for neurodegenerative disease: a promising frontier. Eur J Cell Biol. 2020;99(6):151097. doi: 10.1016/j.ejcb.2020.151097.
   PubMed Web of Science ®Google Scholar
• Boon RA, Dimmeler S. MicroRNAs in myocardial infarction. Nat Rev Cardiol. 2015;12(3):135–142. doi: 10.1038/nrcardio.2014.207.
   PubMed Web of Science ®Google Scholar
• Salic K, De Windt LJ. MicroRNAs as biomarkers for myocardial infarction. Curr Atheroscler Rep. 2012;14(3):193–200. doi: 10.1007/s11883-012-0238-z.
   PubMed Web of Science ®Google Scholar
• Nugroho AB, Stafford N, Zi M, et al. Micro RNA-411 expression improves cardiac phenotype following myocardial infarction in mice. JACC Basic Transl Sci. 2022;7(9):859–875. doi: 10.1016/j.jacbts.2022.05.008.
   PubMedGoogle Scholar
• Zhang X, He X, Jing H, et al. Neonatal rabbit model for pressure-overloaded heart failure and preliminary exploration of mechanism. Ann Thorac Surg. 2021;112(5):1537–1545. doi: 10.1016/j.athoracsur.2020.07.078.
   PubMed Web of Science ®Google Scholar
• Menon A, Abd-Aziz N, Khalid K, et al. miRNA: a promising therapeutic target in cancer. Int J Mol Sci. 2022;23(19):11502. doi: 10.3390/ijms231911502.
   PubMed Web of Science ®Google Scholar
• Dong F, Khalil M, Kiedrowski M, et al. Critical role for leukocyte hypoxia inducible factor-1alpha expression in post-myocardial infarction left ventricular remodeling. Circ Res. 2010;106(3):601–610. doi: 10.1161/CIRCRESAHA.109.208967.
   PubMed Web of Science ®Google Scholar
• Dodd MS, Sousa Fialho MDL, Montes Aparicio CN, et al. Fatty acids prevent hypoxia-inducible factor-1alpha signaling through decreased succinate in diabetes. JACC Basic Transl Sci. 2018;3(4):485–498. doi: 10.1016/j.jacbts.2018.04.005.
   PubMedGoogle Scholar
• Bian P, Ye C, Zheng X, et al. Mesenchymal stem cells alleviate Japanese encephalitis virus-induced neuroinflammation and mortality. Stem Cell Res Ther. 2017;8(1):38. doi: 10.1186/s13287-017-0486-5.
   PubMedGoogle Scholar
• Zhu LP, Tian T, Wang JY, et al. Hypoxia-elicited mesenchymal stem cell-derived exosomes facilitates cardiac repair through miR-125b-mediated prevention of cell death in myocardial infarction. Theranostics. 2018;8(22):6163–6177. doi: 10.7150/thno.28021.
   PubMed Web of Science ®Google Scholar
• Xiong W, Bai X, Xiao H, et al. [Effects of astragaloside IV on exosome secretion and its microRNA-126 expression in human endothelial progenitor cells]. Zhonghua Shao Shang Za Zhi. 2020;36:1183–1190.
   PubMedGoogle Scholar
• Zhu J, Lu K, Zhang N, et al. Myocardial reparative functions of exosomes from mesenchymal stem cells are enhanced by hypoxia treatment of the cells via transferring microRNA-210 in an nSMase2-dependent way. Artif Cells Nanomed Biotechnol. 2018;46(8):1659–1670. doi: 10.1080/21691401.2017.1388249.
   PubMed Web of Science ®Google Scholar
• Xiao C, Wang K, Xu Y, et al. Transplanted mesenchymal stem cells reduce autophagic flux in infarcted hearts via the exosomal transfer of miR-125b. Circ Res. 2018;123(5):564–578. doi: 10.1161/CIRCRESAHA.118.312758.
   PubMed Web of Science ®Google Scholar
• Xia JB, Wu HY, Lai BL, et al. Gene delivery of hypoxia-inducible VEGF targeting collagen effectively improves cardiac function after myocardial infarction. Sci Rep. 2017;7(1):13273. doi: 10.1038/s41598-017-13547-1.
   PubMedGoogle Scholar
• Qu X, Du Y, Shu Y, et al. MIAT is a pro-fibrotic long non-coding RNA governing cardiac fibrosis in post-infarct myocardium. Sci Rep. 2017;7(1):42657. doi: 10.1038/srep42657.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhu P, Wang J, et al. Long noncoding RNA lncHand2 promotes liver repopulation via c-Met signaling. J Hepatol. 2018;69(4):861–872. doi: 10.1016/j.jhep.2018.03.029.
   PubMed Web of Science ®Google Scholar
• Cai L, Qi B, Wu X, et al. Circular RNA Ttc3 regulates cardiac function after myocardial infarction by sponging miR-15b. J Mol Cell Cardiol. 2019;130:10–22. doi: 10.1016/j.yjmcc.2019.03.007.
   PubMed Web of Science ®Google Scholar
• Lionetti V, Cantoni S, Cavallini C, et al. Hyaluronan mixed esters of butyric and retinoic acid affording myocardial survival and repair without stem cell transplantation. J Biol Chem. 2010;285(13):9949–9961. doi: 10.1074/jbc.M109.087254.
   PubMed Web of Science ®Google Scholar
• Zhou X, Zhang W, Jin M, et al. lncRNA MIAT functions as a competing endogenous RNA to upregulate DAPK2 by sponging miR-22-3p in diabetic cardiomyopathy. Cell Death Dis. 2017;8(7):e2929. doi: 10.1038/cddis.2017.321.
   PubMedGoogle Scholar
• Cao X, Ma Q, Wang B, et al. Silencing long non-coding RNA MIAT ameliorates myocardial dysfunction induced by myocardial infarction via MIAT/miR-10a-5p/EGR2 axis. Aging (Albany NY). 2021;13(8):11188–11206. doi: 10.18632/aging.202785.
   PubMedGoogle Scholar
• Zhang F, Wang K, Gao F, et al. Resveratrol pretreatment improved heart recovery ability of hyperglycemic bone marrow stem cells transplantation in diabetic myocardial infarction by down-regulating MicroRNA-34a. Front Pharmacol. 2021;12:632375. doi: 10.3389/fphar.2021.632375.
   PubMed Web of Science ®Google Scholar
• Ma T, Chen Y, Chen Y, et al. MicroRNA-132, delivered by mesenchymal stem cell-derived exosomes, promote angiogenesis in myocardial infarction. Stem Cells Int. 2018;2018:3290372. doi: 10.1155/2018/3290372.
   PubMed Web of Science ®Google Scholar
• Tang MKS, Yue PYK, Ip PP, et al. Soluble E-cadherin promotes tumor angiogenesis and localizes to exosome surface. Nat Commun. 2018;9(1):2270. doi: 10.1038/s41467-018-04695-7.
   PubMedGoogle Scholar
• Lu L, Liu M, Sun R, et al. Myocardial infarction: symptoms and treatments. Cell Biochem Biophys. 2015;72(3):865–867. doi: 10.1007/s12013-015-0553-4.
   PubMed Web of Science ®Google Scholar
• Shafei AE, Ali MA, Ghanem HG, et al. Mesenchymal stem cell therapy: a promising cell-based therapy for treatment of myocardial infarction. J Gene Med. 2017;19(12):e2995. doi: 10.1002/jgm.2995.
   Web of Science ®Google Scholar
• Peng Y, Zhao JL, Peng ZY, et al. Correction: exosomal miR-25-3p from mesenchymal stem cells alleviates myocardial infarction by targeting pro-apoptotic proteins and EZH2. Cell Death Dis. 2020;11(10):845. doi: 10.1038/s41419-020-03025-4.
   PubMed Web of Science ®Google Scholar
• Zhu D, Liu S, Huang K, et al. Intrapericardial exosome therapy dampens cardiac injury via activating Foxo3. Circ Res. 2022;131:e135–e150.
   PubMed Web of Science ®Google Scholar
• Liu X, Li X, Zhu W, et al. Exosomes from mesenchymal stem cells overexpressing MIF enhance myocardial repair. J Cell Physiol. 2020;235(11):8010–8022. doi: 10.1002/jcp.29456.
   PubMed Web of Science ®Google Scholar
• Yin B, Hou XW, Lu ML. Astragaloside IV attenuates myocardial ischemia/reperfusion injury in rats via inhibition of calcium-sensing receptor-mediated apoptotic signaling pathways. Acta Pharmacol Sin. 2019;40(5):599–607. doi: 10.1038/s41401-018-0082-y.
   PubMed Web of Science ®Google Scholar
• Yang L, Liu N, Zhao W, et al. Angiogenic function of astragaloside IV in rats with myocardial infarction occurs via the PKD1-HDAC5-VEGF pathway. Exp Ther Med. 2019;17(4):2511–2518. doi: 10.3892/etm.2019.7273.
   PubMed Web of Science ®Google Scholar
• Sun C, Zeng G, Wang T, et al. Astragaloside IV ameliorates myocardial infarction induced apoptosis and restores cardiac function. Front Cell Dev Biol. 2021;9:671255. doi: 10.3389/fcell.2021.671255.
   PubMed Web of Science ®Google Scholar
• Liang C, Ni GX, Shi XL, et al. Astragaloside IV regulates the HIF/VEGF/notch signaling pathway through miRNA-210 to promote angiogenesis after ischemic stroke. Restor Neurol Neurosci. 2020;38(3):271–282. doi: 10.3233/RNN-201001.
   PubMed Web of Science ®Google Scholar
• Wen Z, Mai Z, Zhu X, et al. Mesenchymal stem cell-derived exosomes ameliorate cardiomyocyte apoptosis in hypoxic conditions through microRNA144 by targeting the PTEN/AKT pathway. Stem Cell Res Ther. 2020;11(1):36. doi: 10.1186/s13287-020-1563-8.
   PubMed Web of Science ®Google Scholar
• Van Der Kwast R, Woudenberg T, Quax PHA, et al. MicroRNA-411 and its 5′-IsomiR have distinct targets and functions and are differentially regulated in the vasculature under ischemia. Mol Ther. 2020;28(1):157–170. doi: 10.1016/j.ymthe.2019.10.002.
   PubMed Web of Science ®Google Scholar
• Ai P, Shen B, Pan H, et al. MiR-411 suppressed vein wall fibrosis by downregulating MMP-2 via targeting HIF-1alpha. J Thromb Thrombolysis. 2018;45(2):264–273. doi: 10.1007/s11239-017-1596-8.
   PubMed Web of Science ®Google Scholar
• Yang F, Huang R, Ma H, et al. miRNA-411 regulates chondrocyte autophagy in osteoarthritis by targeting hypoxia-inducible factor 1 alpha (HIF-1alpha). Med Sci Monit. 2020;26:e921155. doi: 10.12659/MSM.921155.
   PubMed Web of Science ®Google Scholar
• Bonham CA, Kuehlmann B, Gurtner GC. Impaired neovascularization in aging. Adv Wound Care (New Rochelle). 2020;9(3):111–126. doi: 10.1089/wound.2018.0912.
   PubMed Web of Science ®Google Scholar
• Li S, Li S. Effects of transplantation of hypoxia-inducible factor-1alpha genemodified cardiac stem cells on cardiac function of heart failure rats after myocardial infarction. Anatol J Cardiol. 2018;20(6):318–329. doi: 10.14744/AnatolJCardiol.2018.91979.
   PubMed Web of Science ®Google Scholar
• Gonzalez-King H, Garcia NA, Ontoria-Oviedo I, et al. Hypoxia inducible factor-1alpha potentiates jagged 1-mediated angiogenesis by mesenchymal stem cell-derived exosomes. Stem Cells. 2017;35(7):1747–1759. doi: 10.1002/stem.2618.
   PubMed Web of Science ®Google Scholar
• Huang B, Qian J, Ma J, et al. Myocardial transfection of hypoxia-inducible factor-1alpha and co-transplantation of mesenchymal stem cells enhance cardiac repair in rats with experimental myocardial infarction. Stem Cell Res Ther. 2014;5(1):22. doi: 10.1186/scrt410.
   PubMedGoogle Scholar